Cheryl Reicin

Cheryl advises the industry’s largest investors and most innovative startups on highly complex transactions worldwide. With an international reputation for quality and helping clients advance their strategies, Cheryl combines deep knowledge of the market with a business-minded practical approach.

. She represents the entire spectrum of biotech, medical device and health technology companies, from start-ups to large public companies, as well as venture capitalists, investment banks and academic medical centers.

Cheryl is widely recognized for her long track record of helping life sciences companies at all stages formulate and evolve their domestic and international growth strategies, source capital, and develop and optimize their corporate and tax structures. Cheryl has extensive experience advising on venture and later-stage financings, IPOs, M&A, licensing transactions and joint ventures or alliances with strategic partners.

Cheryl has been named WXN’s Canada’s Top 100 Most Powerful Women four times and inducted into its Hall of Fame. She has been repeatedly recognized by LMG Life Sciences as the Canadian Finance & Corporate Attorney of the Year.